This inventor holds 1 USPTO granted patent and 8 published patent applications and 2 EPO patents. Top assignee: Genmab A+s. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Louise Koopman: Innovator in Cancer Therapy
Introduction
Louise Koopman is a prominent inventor based in Utrecht, Netherlands. She has made significant contributions to the field of cancer therapy through her innovative work on antibodies.
Latest Patents
Koopman holds a patent related to antibodies that bind to B7H4. This invention includes bispecific antibodies that also bind to CD3. The patent further encompasses pharmaceutical compositions that utilize these antibodies for therapeutic and diagnostic procedures, particularly in cancer therapy.
Career Highlights
Louise Koopman is associated with Genmab AS, a leading biotechnology company focused on developing innovative antibody-based therapies. Her work has been instrumental in advancing cancer treatment options.
Collaborations
Koopman collaborates with notable colleagues such as Patrick Engelberts and Dennis Verzijl, contributing to a dynamic research environment.
Conclusion
Louise Koopman's innovative work in antibody development represents a significant advancement in cancer therapy, showcasing her dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile